CD8A and myeloid sarcoma: The memory status of CD20-expressing myelin-specific CD8+ T cells was variable, but with an overall significant increase in myelin-specific memory CD20+ CD8+ T cells in MS patients (53.7 ± 10.3%) compared to control subjects (27.0 ± 9.7%) (SI Appendix, Fig. S5B).